BridgeMD
Tests treatment safety and results for Women With Stress Urinary Incontinence
Official title Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence
ClinicalTrials.gov ID: NCT05635175
What this study is testing
- What it's testing
- Urinary incontinence (UI) is estimated to affect 25% à 45 % women all over the world. UI is associated with a poor Quality of life, with a strong level of certainty.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women ≥ 18 ans
- patient with urinary incontinence according to the ICS criteria [3]
- having received a prescription for perineal rehabilitation
- affiliated to french health care insurance
- Patient having read and understood the information letter and signed the consent form
You likely can't join if
- Bladder pathologies (cyst, tumour, interstitial cystitis)
- Neurological pathologies (multiple sclerosis, Parkinson's desease, etc.)
- Pregnant or parturient or breastfeeding woman or absence of proven contraception
- Person deprived of liberty by administrative or judicial decision or a person placed under the safeguard of justice, or guardianship or curatorship
- Physical inability to perform hip abductors exercises (unable to walk or stand independently)
- Women having scheduled continence surgery before the end of physiotherapy sessions at the time of randomization
See the full eligibility criteria
- Women ≥ 18 ans
- patient with urinary incontinence according to the ICS criteria [3]
- having received a prescription for perineal rehabilitation
- affiliated to french health care insurance
- Patient having read and understood the information letter and signed the consent form
- Effective contraception in women of childbearing age (negative urine pregnancy test). For postmenopausal women, a confirmatory diagnosis must be obtained (amenorrhea for at least 12 months before the inclusion visit)
- Bladder pathologies (cyst, tumour, interstitial cystitis)
- Neurological pathologies (multiple sclerosis, Parkinson's desease, etc.)
- Pregnant or parturient or breastfeeding woman or absence of proven contraception
- Person deprived of liberty by administrative or judicial decision or a person placed under the safeguard of justice, or guardianship or curatorship
- Physical inability to perform hip abductors exercises (unable to walk or stand independently)
- Women having scheduled continence surgery before the end of physiotherapy sessions at the time of randomization
- Women having at least one of the continence-specific anticholinergic treatments prescribed before the end of the physiotherapy sessions at the time of randomization
The study team makes the final eligibility decision.
Where it's taking place
- Caen, France
- Rouen, France
- Saint-Étienne-du-Rouvray, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caen, France; Rouen, France; Saint-Étienne-du-Rouvray, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.